NEW YORK, NY, Helaina, the biotechnology company transforming nutrition, announced it has raised $45 million in Series B funding led by Avidity Partners.
Helaina, the biotechnology company transforming nutrition with human equivalent bioactive proteins, announced it has raised $45 million in Series B funding, bringing the company’s total equity funding to $83 million. The round was led by Avidity Partners, with additional investment from Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity and Primary Venture Partners, among other strategic partners.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
By VC News Daily
Source: VC News Daily